DISCLAIMER: Adherence to these guidelines will not ensure successful program implementation in every situation. Furthermore, these guidelines should not be interpreted as setting a standard of point-of-care testing, or be deemed inclusive of all proper methods of point-of-care testing nor exclusive of other methods of point-of-care testing reasonably directed to obtaining the same results. The ultimate judgment regarding the propriety of any specific workflow process must be made by the pharmacist and the patient in light of all the circumstances presented by the individual patient, and the known variability and biological behavior of the disease. This guideline reflects the best available data at the time the guideline was prepared. The specifications of future point-of-care testing programs for SARS-CoV-2 may require revisions to the recommendations in this guideline to reflect new data.